[go: up one dir, main page]

DE69925824D1 - Glutathionderivate und dazugehörige dosisformen - Google Patents

Glutathionderivate und dazugehörige dosisformen

Info

Publication number
DE69925824D1
DE69925824D1 DE69925824T DE69925824T DE69925824D1 DE 69925824 D1 DE69925824 D1 DE 69925824D1 DE 69925824 T DE69925824 T DE 69925824T DE 69925824 T DE69925824 T DE 69925824T DE 69925824 D1 DE69925824 D1 DE 69925824D1
Authority
DE
Germany
Prior art keywords
alkyl group
group
dosage forms
alkenyl group
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69925824T
Other languages
English (en)
Inventor
Kiyoyuki Sakon
Yoshimitsu Naniwa
Mitsuru Kobayashi
Daishiro Miura
Hiroshi Imai
Atsushi Imaizumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Application granted granted Critical
Publication of DE69925824D1 publication Critical patent/DE69925824D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DE69925824T 1998-04-16 1999-04-16 Glutathionderivate und dazugehörige dosisformen Expired - Lifetime DE69925824D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10635998 1998-04-16
PCT/JP1999/002044 WO1999054346A1 (en) 1998-04-16 1999-04-16 Glutathione derivatives and dosage forms thereof

Publications (1)

Publication Number Publication Date
DE69925824D1 true DE69925824D1 (de) 2005-07-21

Family

ID=14431564

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69925824T Expired - Lifetime DE69925824D1 (de) 1998-04-16 1999-04-16 Glutathionderivate und dazugehörige dosisformen

Country Status (10)

Country Link
US (2) US6627732B1 (de)
EP (1) EP1072608B1 (de)
JP (1) JP4059627B2 (de)
KR (1) KR20010042752A (de)
AT (1) ATE297945T1 (de)
AU (1) AU766515B2 (de)
CA (1) CA2328731A1 (de)
DE (1) DE69925824D1 (de)
TW (1) TW576838B (de)
WO (1) WO1999054346A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029695B2 (en) 2001-07-10 2006-04-18 Telik, Inc. Therapeutic compositions containing glutathione analogs
US6747009B2 (en) * 2002-09-19 2004-06-08 Universiteit Leiden Peptidomimetic glutathione analogs
US8198247B2 (en) * 2004-12-21 2012-06-12 Telik, Inc. Process for and intermediates in the preparation of canfosfamide and its salts
DK1833978T3 (da) 2005-01-06 2009-02-09 Telik Inc Tripeptid- og tetrapeptidthioethere
US8067380B2 (en) 2005-12-19 2011-11-29 Industrial Technology Research Institute Glutathione-based delivery system
US7446096B2 (en) * 2005-12-19 2008-11-04 Industrial Technology Research Institute Glutathione based delivery system
EP2123284A4 (de) * 2007-03-20 2011-07-06 Univ Osaka Vorbeugender und/oder therapeutischer wirkstoff für herzinfarkte
ES2322121B1 (es) * 2007-12-10 2010-04-19 Consejo Superior De Investigaciones Cientificas Nuevos derivados de aminoacidos dicarboxilicos y su aplicacion en el tratamiento de enfermedades neurodegenerativas.
US8609604B2 (en) 2009-12-28 2013-12-17 N.V. Perricone Llc Methods of improving the appearance of aging skin
US8580742B2 (en) * 2010-03-05 2013-11-12 N.V. Perricone Llc Topical glutathione formulations for menopausal skin
US20110160144A1 (en) * 2009-12-28 2011-06-30 Perricone Nicholas V Topical Acyl Glutathione Formulations
JP2013528214A (ja) 2010-06-07 2013-07-08 テリック,インコーポレイテッド 結晶性エザチオスタット塩酸塩非溶媒和物d型の調製
CN102917694A (zh) * 2010-06-07 2013-02-06 泰立克公司 依泽替米贝的片剂制剂
EP2724729B1 (de) 2011-06-21 2018-12-26 Nitto Denko Corporation Apoptoseauslöser
US20140120157A1 (en) * 2012-09-19 2014-05-01 Georgetown University Targeted liposomes
JP6340162B2 (ja) 2012-12-20 2018-06-06 日東電工株式会社 アポトーシス誘導剤
US10093931B2 (en) 2014-06-17 2018-10-09 Nitto Denko Corporation Apoptosis inducer
US10264976B2 (en) 2014-12-26 2019-04-23 The University Of Akron Biocompatible flavonoid compounds for organelle and cell imaging
RU2692065C1 (ru) * 2018-04-05 2019-06-20 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Глутатионаммониевые соли o,o-диорганилдитиофосфорных кислот, обладающие антиоксидантной и противоопухолевой активностью
ES2972334T3 (es) 2018-11-16 2024-06-12 Nitto Denko Corp Formulación y métodos de administración de interferencia de ARN para tumores malignos
US11419849B1 (en) 2019-02-06 2022-08-23 Kitt Bio, Inc. Methods and products for adverse effects of air travel, jet lag, or a change to a sleep wake timing cycle
WO2020230701A1 (ja) 2019-05-14 2020-11-19 学校法人 慶應義塾 抗腫瘍剤及び配合剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995005863A1 (en) 1993-08-27 1995-03-02 St. Paul Medical, Inc. Needleless iv medical delivery system
WO1996040205A1 (en) * 1995-06-07 1996-12-19 Terrapin Technologies, Inc. Metabolic effects of certain glutathione analogs
WO1999037802A1 (en) 1998-01-21 1999-07-29 Telik, Inc. Methods to identify myelostimulants
CN1185008C (zh) 1999-01-27 2005-01-19 泰立克公司 含有谷胱甘肽类似物的治疗用组合物

Also Published As

Publication number Publication date
ATE297945T1 (de) 2005-07-15
JP4059627B2 (ja) 2008-03-12
US20040018985A1 (en) 2004-01-29
AU766515B2 (en) 2003-10-16
EP1072608A1 (de) 2001-01-31
AU3344599A (en) 1999-11-08
US6627732B1 (en) 2003-09-30
TW576838B (en) 2004-02-21
WO1999054346A1 (en) 1999-10-28
KR20010042752A (ko) 2001-05-25
EP1072608A4 (de) 2001-09-19
EP1072608B1 (de) 2005-06-15
CA2328731A1 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
DE69925824D1 (de) Glutathionderivate und dazugehörige dosisformen
BR0109703A (pt) Derivados de piperazina
NO2011026I2 (no) Eribulin eller et farmasøytisk akseptabelt salt derav
BR0016555A (pt) Composições farmacêuticas que proporcionam concentrações acrescidas de droga
MA26548A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol.
DK1004578T3 (da) 5-oxo-pyrrolidin-2-carboxylsyrehydroxamidderivater
ATE185792T1 (de) Stilbenderivate und diese enthaltende pharmazeutische zusammensetzungen
CY1108367T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
PT1129093E (pt) Derivados de pirazpolopirimidinona para o tratamento da impotencia
PT1235799E (pt) Forma polimorfica de atorvastatina-calcio
DE69907977D1 (de) Pyrrolobenzodiazepine
BR9906915A (pt) Composição que compreende mel, ou pelo menos um óleo essencial e/ou pelo menos um derivado de um óleo essencial.
PE14199A1 (es) Agonistas de 5-ht1f
PT911331E (pt) Compostos de dibenzoxazepina substituidos composicoes farmaceuticas e metodos de utilizacao
ATE224714T1 (de) Behandlung von tinnitus mit neuroprotektiven wirkstoffen
TR200003736T2 (tr) Anksiyete durumlarına ya da depresyona bağlı değişikliklerin önlenmesi
NO20014925L (no) Farmasöytiske forbindelser
BR0300709A (pt) Sal de perindopril e as composições farmacêuticas contendo o mesmo
DE69920362D1 (de) Neue Makrolidderivate
DE69913697D1 (de) Naphtho- und dihydrobenzothiophenderivate als cytotoxische antitumormittel
PA8531701A1 (es) Derivados de pirimidina
EP1040832A4 (de) Vitamin d3 enthaltende cremen
TR199901782T2 (xx) Migren tedavisi i�in ibuprofen ve domperidon ihtiva eden farmas�tik bile�imler.
ATE250021T1 (de) Hydroxycyclopentanone
ID25478A (id) Agonis 5-ht1f

Legal Events

Date Code Title Description
8332 No legal effect for de